1Kautz L,Gabayan V,Wang X. Ross R.Atherosclerosis-aninflammatory disease[J].Cell Reports,2013,(05):1436-1442.
2Ross R. Atherosclerosis-an inflammatory disease[J].New England Journal of Medicine,1999,(02):115-126.
3Libby P,Ridker PM,Maseri A. Inflammation and atherosclero-sis[J].CIRCULATION,2002,(09):1135-1143.
4Lee BS,Choi JY,Kim JY. Simvastatin and losartan differ-entially and synergistically inhibit atherosclerosis in apolipopro-tein e(-/-) mice[J].Korean Circulation Journal,2012,(08):543-550.
5Katsiki N,Tziomalos K,Chatzizisis Y. Effect of HMG-CoA reductase inhibitors on vascular cell apoptosis:beneficial or de-trimental[J].ATHEROSCLEROSIS,2010,(01):9-14.
6Liang SL,Liu H,Zhou A. Lovastatin-induced apoptosis in macro-phages through the Rac1/Cdc42/JNK pathway[J].Journal of Immunology,2006,(01):651-656.
7Schmidt-Lucke C,Fichtlscherer S,R(o)ssig L. Improvementof endothelial damage and regeneration indexes in patients with coronary artery disease after 4 weeks of statin therapy[J].ATHEROSCLEROSIS,2010,(01):249-254.
8Davis HR,Lowe RS,Neff DR. Effects of ezetimibe on atheroscle-rosis in preclinical models[J].ATHEROSCLEROSIS,2011,(02):266-278.
9Bays H,Stein EA. Pharmacotherapy for dyslipidaemia-currenttherapies and future agents[J].EXPERT OPINION ON PHARMACOTHERAPY,2003,(11):1901-1938.
10Kühnast S,Louwe MC,Heemskerk MM. Niacin ReducesAtherosclerosis Development in APOE*3Leiden.CETP Mice Mainlyby Reducing NonHDL-Cholesterol[J].PLoS One,2013,(06):664-667.
二级参考文献43
1[27]Tatti P,Pahor M,Byington RP,et al.Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM.Diabetes Care,1998,21:597-603.
2[28]Grossman E,Messerli FH.Are calcium antagonists beneficial in diabetic patients with hypertension? Am J Med,2004,116:44-49.
6[6]Millar JA,McLean KA,Sumner DJ,et al.The effect of the calcium antagonist nifedipine on pressor and aldosterone responses to angiotensin Ⅱ in normal man.Eur J Clin Pharmacol,1983,24:315-321.
7[7]Pedrinelli R,Taddei S,Salvetti A.Calcium entry blockade and alpha-adrenergic vascular reactivity in human beings:differences between nicardipine and verapamil.Clin Pharmacol Ther,1989,45:285-290.
8[8]Krishna GG,Riley LJ Jr,Deuter G,et al.Natriuretic effect of calcium-channel blockers in hypertensives.Am J Kidney Dis,1991,18:566-572.
10[10]Chobanian AV,Bakris GL,Black HR,et al.The Seventh Report of the Joint National Committee on Prevention,Detection,Evaluation,and Treatment of High Blood Pressure:the JNC 7 report.JAMA,2003,289:2560-2572.
